Diterpenoid DGT alleviates atopic dermatitis-like responses in vitro and in vivo via targeting IL-4Rα.
Jingjing GaoDong LiZhangyang FengXiaoqiang ZhuFei YangBiyan ZhangMingming HuYanping WangHaimei FengYunhui YuQing XieZijun ChenYunsen LiPublished in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
DGT's potent anti-inflammatory effects and good safety profile suggest that it is a potential candidate for the treatment of atopic dermatitis.